A prospective registry study of a primary melanoma gene-signature to predict sentinel node (SN) status and determine its prognostic value for more accurate staging of SN-negative melanoma patients

Administered By

Awarded By

Contributors

Start/End

  • July 29, 2022 - March 31, 2027